| Physicians’ Program May 02, 2026 (Saturday) | Day 2 | Adult HSCT | KS Main Auditorium | ||
| Time (IST) | Session/Topic | Chairperson/Speaker |
| 07:45 AM – 09:00 AM | Session 1: BEST ORAL PAPERS (6 mins presentation + 2 mins discussion) | Judges: Dr Alok Srivastava, Dr Sanjeevan Sharma, Dr Sandip Shah |
| Matching matters – The impact of HLA-B Leader Status on the overall survival in children undergoing haploidentical HSCT: A 10-Year Single-Centre Analysis (Abstract ID: 62) | Krithika Krishnakumar (Apollo Cancer Centre, Chennai) | |
| Factors Affecting Outcomes in Patients Undergoing Ptcy Based Haploidentical Transplants for Hematological Malignancies in the Era of KIR Typing: Experience from a Tertiary Care Centre in India (Abstract ID: 177) | Gourav Gopal Bain (ACTREC, Tata Memorial Centre, Navi Mumbai) | |
| Late Effects and Long-term Survival of Recipients of Total Body Irradiation versus Non-TBI Conditioning in Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Centre Study from India (Abstract ID: 45) | Manaswinee Mallik (PGIMER, Chandigarh) | |
| Establishing a Stability Framework for Defining Expiry of Cryopreserved Hematopoietic Progenitor Cell Products in an Indian Transplant Centre (Abstract ID: 198) | Shouriyo Ghosh (Tata Medical Center, Kolkata) | |
| Enhancing hand hygiene compliance among healthcare workers: a quality improvement initiative from August 2025 to February 2026 (Abstract ID: 186) | Usha Vikas Gawade (ACTREC, Tata Memorial Centre, Panwel) | |
| Predictors of outcome post autologous stem cell transplant in patients who have received check point inhibitor-based salvage therapy in relapsed/refractory Hodgkin lymphoma- A ISBMT lymphoma working group study. (Abstract ID: 88) | Lingaraj Nayak (ACTREC, Tata Memorial Centre, Navi Mumbai) | |
| Thalassemia GVHD-Free Survival Following Allogeneic Hematopoietic Stem Cell Transplantation in Pesaro Class III: A Single-Center Experience (Abstract ID: 115) | John Abraham (Christian Medical College, Ludhiana) | |
| Feasibility, Safety, and Survival Outcomes of Structured Home-Based Monitoring and Care Using a Standardized Protocol After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Resource-Limited Setting. (Abstract ID: 32) | Siddhesh Arun Kalantri (NAMCO Hospital, Nashik) | |
| 09:00 AM – 09:45 AM | TRACK 1: ADULT – TRANSPLANT IN AUTOIMMUNE DISORDERS | Chairpersons: Dr Radhika Setti, Dr Ganapathi Bhat |
| 09:00 AM – 09:15 AM | A Decade Of HSCT For Multiple Sclerosis | Dr Pravas Mishra |
| 09:15 AM – 09:45 AM | Audience Interaction And Panel Discussion: HSCT or Car T For Autoimmune Disorders – Patient Selection | Moderator: Dr Mukul Aggarwal Panelists: Dr Saurabh Bhave, Dr Sarita Rani Jaiswal, Dr Priyanka Samal |
| 09:45 AM – 10:15 AM | Coffee Break | |
| 10:15 AM – 10:30 AM | ISBMT INAUGURAL FUNCTION | |
| 10:30 AM – 12:00 PM | Presidential Symposium: “Novel Insights Into The Biology And Management Of Acute Graft Versus Host Disease” | Chairpersons: Dr Alok Srivastava, Dr Navin Khattry |
| 10:30 AM – 10:50 AM | EBMT | Dr Anna Sureda |
| 10:50 AM – 11:10 AM | ASTCT | Dr Sophie Paczesny |
| 11:10 AM – 11:30 AM | APBMT | Prof Takanori Teshima |
| 11:30 AM – 11:50 AM | ISBMT | Dr Navin Khattry |
| 11:50 AM – 12:00 PM | Discussion | |
| 12:00 PM – 01:00 PM | Sponsored Symposium 3 SANOFI: From Prevention to Treatment: Evolving Strategies and the Emerging Impact of Belumosudil in cGVHD | |
| 01:00 PM – 02:00 PM | Lunch | |
| 02:00 PM – 03:30 PM | TRACK 2: ADULTS – CONDITIONING AND SUPPORTIVE CARE IN THE ELDERLY | Chairpersons: Dr Tapan Saikia, Dr Renjith Verghese |
| 02:00 PM – 02:15 PM | Tailored Conditioning For The Elderly | Lt Gen (Dr) Velu Nair (Retd) |
| 02:15 PM – 02:30 PM | Caring For The Heart In HSCT | Dr Pankaj Malhotra |
| 02:30 PM – 02:45 PM | Watch The Kidneys! | Dr Rajib De |
| 02:45 PM – 03:30 PM | Audience Interaction And Panel Discussion: Counselling Elderly For HSCT – Case Based Discussion | Moderator: Dr Dinesh Bhurani, Panelists: Dr Reshma Roshan, Dr Santosh Devadas, Dr Nataraj KS |
| 03:30 PM – 05:00 PM | TRACK 3: ADULT – MYELOMA & LYMPHOMA | Chairpersons: Dr Bhausaheb Bagal, Dr Rajasekar Thirugnanam |
| 03:30 PM – 03:45 PM | Role Of HSCT In Hodgkins In The Era Of Immunotherapy | Dr Anna Sureda |
| 03:45 PM – 04:00 PM | Is There A Role For HSCT In DLBCL In This Era? | Dr Ashish Dixit |
| 04:00 PM – 04:15 PM | HSCT In Myeloma – Is It Still Relevant In The Era Of BITEs And CARs | Dr Lalit Kumar |
| 04:15 PM – 05:00 PM | Audience Interaction And Panel Discussion: Myeloma – Choices are Plenty, How do I Choose? | Moderator: Dr Sameer Mellinkeri Panelists: Dr Sumit Mirgh, Dr Parathan Karunakaran, Dr Gaurav Prakash |
| 05:00 PM – 06:00 PM | Coffee Break/ Poster Viewing | |
| 05:00 PM – 06:45 PM | Sponsored Symposium 5 J&J : Teclistamab in the Real World: Insights from Indian Experience for Relapse Refractory Multiple Myeloma | |
| 06:00 PM – 07:00 PM | Sponsored Symposium 7 ROCHE : Evolving Landscape in DLBCL – Bispecifics and Beyond | |
| 07:00 PM – 08:30 PM | Working Groups Update, ISBMT Registry Meeting and AGM | Dr Sharat Damodar, Ms Sadhana Kannan, Dr Navin Khattry |
| 08:30 PM onwards | Dinner | |
Quick Links
Reach Us
Venue:
Advanced Centre for Treatment,
Research and Education in Cancer (ACTREC), Tata Memorial Centre,
Kharghar, Navi Mumbai.
Ms. Jolly Thomas
Operation Manager
E: om@isbmt.
Ms. Rashmi Mundada
Sr. Operation Executive
E: oe@isbmt.org
Website: www.isbmt.org